Intrapleural targeted therapies (anti-VEGF and anti-EGFR) in the model of malignant pleural effusion | Zendy

Milena Marques Pagliarelli Acencio | Zendy; Juliana Puka | Zendy; Vanessa Alvarenga | Zendy; Vanessa Martins | Zendy; Mariana Lombardi Peres de Carvalho | Zendy; Evaldo Marchi | Zendy; Vera Luíza Capelozzi | Zendy; Lisete R. Teixeira | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Intrapleural targeted therapies (anti-VEGF and anti-EGFR) in the model of malignant pleural effusion

Author(s) -

Milena Marques Pagliarelli Acencio,

Juliana Puka,

Vanessa Alvarenga,

Vanessa Martins,

Mariana Lombardi Peres de Carvalho,

Evaldo Marchi,

Vera Luíza Capelozzi,

Lisete R. Teixeira

Publication year - 2017

Publication title -

oncotarget

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.373

H-Index - 127

ISSN - 1949-2553

DOI - 10.18632/oncotarget.21362

Subject(s) - kras , medicine , malignant pleural effusion , cancer research , egfr inhibitors , pleural effusion , epidermal growth factor receptor , vascular endothelial growth factor , pathology , cancer , colorectal cancer , vegf receptors

Malignant pleural effusion has few options of treatment and drugs administrated by different routes can lead to a less permissive microenvironment for the development of malignant pleural disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research